NASDAQ · FTXH
First Trust Nasdaq Pharmaceuticals ETF
$44.24+$0.47 (+1.07%)
First Trust Nasdaq Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.21% below the high.
Loading market information…
AMEX · VRAI · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:57 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Virtus Real Asset Income ETF’s quoted price sits in the upper half of its reported 52-week range, 1.3% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Virtus Real Asset Income ETF’s forward annual dividend is $1.04 per share, paid quarterly. The forward yield is 3.6% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the underlying index. The underlying index is designed to track the performance of U.S.-listed "Real Asset" companies, as defined by Indxx, LLC. The underlying index includes common stock, real estate investment trusts, master limited partnerships, American depositary receipts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 06:22 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$44.24+$0.47 (+1.07%)
First Trust Nasdaq Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.21% below the high.
$84.68-$1.34 (-1.56%)
First Trust Alerian U.S. NextGen Infrastructure ETF’s quoted price sits in the upper half of its reported 52-week range, 7.02% below the high.
$47.86-$0.25 (-0.52%)
Leuthold Select Industries ETF’s quoted price sits in the upper half of its reported 52-week range, 6.8% below the high.
$77.25-$2.99 (-3.73%)
Putnam Emerging Markets Ex-China ETF’s quoted price sits in the lower half of its reported 52-week range, 18.85% below the high.
$35.26-$0.68 (-1.89%)
Infrastructure Capital Small Cap Income ETF’s quoted price sits in the lower half of its reported 52-week range, 12.38% below the high.
$48.29+$0.37 (+0.76%)
First Trust Bloomberg Shareholder Yield ETF’s quoted price sits in the upper half of its reported 52-week range, 0.43% below the high.
$55.45+$0.37 (+0.67%)
First Trust Emerging Markets Equity Select ETF’s quoted price sits in the upper half of its reported 52-week range, 6.03% below the high.
$32.63$0.00 (0.0%)
Northern Trust Emerging Markets Quality Low Volatility ETF’s quoted price sits in the upper half of its reported 52-week range, 7.19% below the high.
